CO-DIRECTORS
OTHER FACULTY (in alphabetical order)
| |
 |
|
Eliot A. Brinton, M.D.
eliot.brinton@utah.edu
801-581-3888x274
Dr. Brinton obtained his M.D. from the University of Utah, trained in Internal Medicine at Duke University, and in Endocrinology at the University of Washington. He has been on the faculty of the Rockefeller University, Wake Forest University, and the University of Arizona. He served for seven years as Chief of the Section of Metabolism, Endocrinology and Nutrition at the Phoenix VA Medical Center where he was also President of the Phoenix Cross-town Endocrine Society and the Arizona Atherosclerosis Club. Currently, he is Director of the Metabolism Section of Cardiovascular Genetics, and Associate Professor at the University of Utah School of Medicine in Salt Lake City. He is President of the Utah Atherosclerosis Society, President-elect of the Pacific Lipid Association and founding board member of both the National Lipid Association and of the American Board of Clinical Lipidology. He serves on the editorial boards of the Journal of Clinical Lipidology, Lipids Online, the Journal of Managed Care Pharmacy, and Future Lipidology.
|
| |
 |
|
Nazeem Nanjee, Ph.D.
nazeem.nanjee@utah.edu
801-581-3888x201
M. Nazeem Nanjee was born in Kenya and educated in England, with a BSc in Physiology and a PhD in Biochemistry from the University of London. He served as Assistant Professor of Internal Medicine at Wake Forest University, Winston-Salem (1988-1993), and as co-director of the Cardiovascular Biochemistry Unit at St. Bartholomew’s Medical College (UK; 1994-2002). Dr Nanjee was recruited to the University of Utah in September 2003. Presently, he is Research Associate Professor and Director of Metabolism Research Laboratory in the Cardiovascular Genetics Division. His research efforts are aimed principally at identifying the molecular basis of the association of coronary heart disease with high-density lipoproteins, to understand the factors that regulate their synthesis and metabolism, and to apply that knowledge to the prevention of atherosclerosis and its clinical complications. Dr Nanjee’s work on extravascular lipoprotein metabolism, using long-term peripheral lymph vessel cannulation in humans, has made unique contributions to our understanding of the roles of HDLs in reverse cholesterol transport, thrombosis and oxidative stress (e.g., J. Lipid Res 2002; 42:1586).
|
|
